Skip to main content
Erschienen in: Pediatric and Developmental Pathology 4/2005

01.08.2005 | Case Report

Striking Facial Dysmorphisms and Restricted Thymic Development in a Fetus with a 6-Megabase Deletion of Chromosome 14q

verfasst von: J. M. de Pater, P. G. J. Nikkels, M. Poot, M. J. Eleveld, R. H. Stigter, C. J. M. van der Sijs-Bos, W. H. Loneus, J. J. M. Engelen

Erschienen in: Pediatric and Developmental Pathology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

During routine ultrasound screening at 12 weeks 5 days of gestation, a nuchal translucency of 7 mm, an omphalocele, and fetal hydrops were found and prompted chorionic villus sampling at 13 weeks 2 days. Chromosome analysis showed an unbalanced karyotype with an abnormal chromosome 14. The mother was a carrier of a translocation karyotype 46,XX,t(13;14) (q34;q32.2). In the fetus this gave rise to a partial trisomy 13q and partial monosomy 14q (fetal karyotype: 46,XX,der[14]t[13;14][q34;q32.2]). By Array-CGH on DNA extracted from a postmortem skin culture, a duplication of approximately 1.7 Mbp of the distal part of chromosome 13q34 and a deletion of approximately 6.0 Mbp of the distal part of chromosome 14q32.2 was demonstrated. Postmortem findings after termination of pregnancy at 14 weeks 6 days included, among others, a severe hypoplasia of the median part of the maxilla, no recognizable nose, a broad median palatoschisis, nonlobulated lungs, a horseshoe kidney with multicystic dysplasia, and decreased development of cortical cellularity in the thymus. These clinical manifestations and autopsy findings of the fetus are compared with those of previously published cases and the possible involvement in this pathology of the YY1 and JAG2 transcription factors and the BCL11b and SIVA-1 regulators of thymic development is discussed.
Literatur
1.
Zurück zum Zitat Van Karnebeek CDM, Quik S, Sluijter S, Hulsbeek MMF, Hoovers JMN, Hennekam RCM. Further delineation of the chromosome 14q terminal deletion syndrome. Am J Med Genet 2002;110:65–72CrossRefPubMed Van Karnebeek CDM, Quik S, Sluijter S, Hulsbeek MMF, Hoovers JMN, Hennekam RCM. Further delineation of the chromosome 14q terminal deletion syndrome. Am J Med Genet 2002;110:65–72CrossRefPubMed
2.
Zurück zum Zitat Schinzel A. Catalogue of Unbalanced Chromosome Aberrations in Man. Berlin: Walter de Gruyter, 2001;585–587 Schinzel A. Catalogue of Unbalanced Chromosome Aberrations in Man. Berlin: Walter de Gruyter, 2001;585–587
3.
Zurück zum Zitat Wigglesworth. Perinatal Pathology, 2nd ed. Philadelphia: W.B. Saunders, 1996;165–169. Wigglesworth. Perinatal Pathology, 2nd ed. Philadelphia: W.B. Saunders, 1996;165–169.
4.
Zurück zum Zitat Siebert RJ, Nyberg DA, Kapur RP. Cerebral mantle thickness: a measurement useful in anatomic diagnosis of fetal ventriculomegaly. Pediatr Dev Pathol 1999;2:168–175CrossRefPubMed Siebert RJ, Nyberg DA, Kapur RP. Cerebral mantle thickness: a measurement useful in anatomic diagnosis of fetal ventriculomegaly. Pediatr Dev Pathol 1999;2:168–175CrossRefPubMed
5.
Zurück zum Zitat Lichter P, Cremer T, Borden J, Manuelidis L, Ward DC. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum Genet 1988;88:224–234CrossRef Lichter P, Cremer T, Borden J, Manuelidis L, Ward DC. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum Genet 1988;88:224–234CrossRef
6.
Zurück zum Zitat Veugelers M, De Cat B, Delande N, Esselens C, Bonk I, Vermeesch J, Marynen P, Fryns JP, David G. A 4-Mb BAC/PAC contig and complete genomic structure of the GPC5/GPC6 gene cluster on chromosome 13q32. Matrix Biol 2001;20:375–385CrossRefPubMed Veugelers M, De Cat B, Delande N, Esselens C, Bonk I, Vermeesch J, Marynen P, Fryns JP, David G. A 4-Mb BAC/PAC contig and complete genomic structure of the GPC5/GPC6 gene cluster on chromosome 13q32. Matrix Biol 2001;20:375–385CrossRefPubMed
7.
Zurück zum Zitat Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 1995;9:132–140CrossRefPubMed Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 1995;9:132–140CrossRefPubMed
8.
Zurück zum Zitat Joos S, Falk MH, Lichter P, Haluska FG, Henglein B, Lenoir GM, Bornkamm GW. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kB. Hum Mol Genet 1992;1:625–632PubMed Joos S, Falk MH, Lichter P, Haluska FG, Henglein B, Lenoir GM, Bornkamm GW. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kB. Hum Mol Genet 1992;1:625–632PubMed
9.
Zurück zum Zitat de Pater JM, Poot M, Beemer FA, Bijlsma JB, Hack WWM, van Dam WM, Eleveld MJ, Loneus WH, Engelen JJM. Virilization of the external genitalia and severe mental retardation in a girl with an unbalanced translocation 1;18 [online citation]. Eur J Med Genet 2005;48 de Pater JM, Poot M, Beemer FA, Bijlsma JB, Hack WWM, van Dam WM, Eleveld MJ, Loneus WH, Engelen JJM. Virilization of the external genitalia and severe mental retardation in a girl with an unbalanced translocation 1;18 [online citation]. Eur J Med Genet 2005;48
10.
Zurück zum Zitat Vissers LE, de Vries BB, Osoegawa K, Janssen IM, Feuth T, Choy CO, Straatman H, van der Vliet W, Huys EH, van Rijk A, Smeets D, van Ravenswaaij-Arts CM, Knoers NV, van der Burgt I, de Jong PJ, Brunner HG, van Kessel AG, Schoenmakers EF, Veltman JA. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003;73:1261–1270CrossRefPubMed Vissers LE, de Vries BB, Osoegawa K, Janssen IM, Feuth T, Choy CO, Straatman H, van der Vliet W, Huys EH, van Rijk A, Smeets D, van Ravenswaaij-Arts CM, Knoers NV, van der Burgt I, de Jong PJ, Brunner HG, van Kessel AG, Schoenmakers EF, Veltman JA. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003;73:1261–1270CrossRefPubMed
11.
Zurück zum Zitat Tharapel SA, Lewandowski RC, Tharapel AT, Wilroy RS Jr. Phenotype-karyotype correlation in patients trisomic for various segments of chromosome 13. J Med Genet 1986;23:310–315PubMed Tharapel SA, Lewandowski RC, Tharapel AT, Wilroy RS Jr. Phenotype-karyotype correlation in patients trisomic for various segments of chromosome 13. J Med Genet 1986;23:310–315PubMed
12.
Zurück zum Zitat Rogers JF. Clinical delineation of proximal and distal partial 13q trisomy. Clin Genet 1984;25:221–229PubMed Rogers JF. Clinical delineation of proximal and distal partial 13q trisomy. Clin Genet 1984;25:221–229PubMed
13.
Zurück zum Zitat Reid Sutton V, Shaffer LG. Search for imprinted regions on chromosome 14: comparison of maternal and paternal UPD cases with cases of chromosome 14 deletion. Am J Med Genet 2000;93:381–387CrossRefPubMed Reid Sutton V, Shaffer LG. Search for imprinted regions on chromosome 14: comparison of maternal and paternal UPD cases with cases of chromosome 14 deletion. Am J Med Genet 2000;93:381–387CrossRefPubMed
14.
Zurück zum Zitat Anyadike IO. A rare genetic karyotype. Clin J Diagn 1991;1:39–45 Anyadike IO. A rare genetic karyotype. Clin J Diagn 1991;1:39–45
15.
Zurück zum Zitat Uehara S, Akai Y, Yakeyama Y, Okamura K, Takabayashi T, Yajima A, Natsui M, Nakai H. A case of a female infant with simultaneous occurrence of the novo terminal deletions on chromosomes 14q and 20p. Clin Genet 1993;43:28–33PubMed Uehara S, Akai Y, Yakeyama Y, Okamura K, Takabayashi T, Yajima A, Natsui M, Nakai H. A case of a female infant with simultaneous occurrence of the novo terminal deletions on chromosomes 14q and 20p. Clin Genet 1993;43:28–33PubMed
16.
Zurück zum Zitat Meschede D, Exeler R, Wittwer B, Horst J. Submicroscopic deletion in 14q32.3 through a de novo tandem translocation between 14q and 21p. Am J Med Genet 1998;80:443–447CrossRefPubMed Meschede D, Exeler R, Wittwer B, Horst J. Submicroscopic deletion in 14q32.3 through a de novo tandem translocation between 14q and 21p. Am J Med Genet 1998;80:443–447CrossRefPubMed
17.
Zurück zum Zitat Turleau C, de Grouchy J, Chavin-Colin F, Dore F, Seger J, Dautzenberg MD, Arthuis M, Jeanson C. Two patients with interstitial del(14q), one with features of Holt-Oram syndrome. Exclusion mapping of PI (alpha-1-antitrypsin). Ann Genet 1984;27:237–240PubMed Turleau C, de Grouchy J, Chavin-Colin F, Dore F, Seger J, Dautzenberg MD, Arthuis M, Jeanson C. Two patients with interstitial del(14q), one with features of Holt-Oram syndrome. Exclusion mapping of PI (alpha-1-antitrypsin). Ann Genet 1984;27:237–240PubMed
18.
Zurück zum Zitat Masada CT, Olney AH, Fordyce R, Sanger WG. Partial deletion of 14q and partial duplication of 14q in sibs: testicular mosaicism for t(14q;14q) as a common mechanism. Am J Med Genet 1989;34:528–534.CrossRefPubMed Masada CT, Olney AH, Fordyce R, Sanger WG. Partial deletion of 14q and partial duplication of 14q in sibs: testicular mosaicism for t(14q;14q) as a common mechanism. Am J Med Genet 1989;34:528–534.CrossRefPubMed
19.
Zurück zum Zitat Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol 1999;19:7237–7244PubMed Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol 1999;19:7237–7244PubMed
20.
Zurück zum Zitat Jiang R, Lan Y, Chapman HD, Shawber C, Norton CR, Serreze DV, Weinmaster G, Gridley T. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev 1998;12:1046–1057PubMed Jiang R, Lan Y, Chapman HD, Shawber C, Norton CR, Serreze DV, Weinmaster G, Gridley T. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev 1998;12:1046–1057PubMed
21.
Zurück zum Zitat Py B, Slomianny C, Auberger P, Petit PX, Benichou S. Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. J Immunol 2004;172:4008–4017PubMed Py B, Slomianny C, Auberger P, Petit PX, Benichou S. Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. J Immunol 2004;172:4008–4017PubMed
22.
Zurück zum Zitat Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y, Hitomi J, Yamamoto T, Utsuyama M, Niwa O, Aizawa S, Kominami R. Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol 2003;4:533–539CrossRefPubMed Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y, Hitomi J, Yamamoto T, Utsuyama M, Niwa O, Aizawa S, Kominami R. Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol 2003;4:533–539CrossRefPubMed
Metadaten
Titel
Striking Facial Dysmorphisms and Restricted Thymic Development in a Fetus with a 6-Megabase Deletion of Chromosome 14q
verfasst von
J. M. de Pater
P. G. J. Nikkels
M. Poot
M. J. Eleveld
R. H. Stigter
C. J. M. van der Sijs-Bos
W. H. Loneus
J. J. M. Engelen
Publikationsdatum
01.08.2005
Erschienen in
Pediatric and Developmental Pathology / Ausgabe 4/2005
Print ISSN: 1093-5266
Elektronische ISSN: 1615-5742
DOI
https://doi.org/10.1007/s10024-005-0041-8

Weitere Artikel der Ausgabe 4/2005

Pediatric and Developmental Pathology 4/2005 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie